<DOC>
	<DOCNO>NCT00257387</DOCNO>
	<brief_summary>Evaluate incidence acute rejection 12 month transplantation subject receive induction therapy cyclosporine microemulsion ( CsA ) Rapamune follow CsA dose reduction ( Phase I ) subject receive induction therapy CsA Rapamune follow CsA discontinuation ( Phase II ) Chinese de novo renal allograft recipient .</brief_summary>
	<brief_title>Study Evaluating Cyclosporine Dose Reduction Cyclosporine Elimination Chinese Kidney Transplants</brief_title>
	<detailed_description />
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Subjects endstage renal disease schedule receive primary renal allograft cadaveric donor , livingunrelated donor , livingrelated HLAmismatched donor . Subjects must least 18 year age . Subjects active major infection , include active hepatitis B C infection , HIV , decrease platelet , elevate lipid , multiple organ transplant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Kidney</keyword>
	<keyword>Kidney Transplant</keyword>
</DOC>